Contents

1............ Name............................................................................................................................. 1

2............ Commencement............................................................................................................. 1

3............ Authority....................................................................................................................... 1

4............ Schedules...................................................................................................................... 1

Schedule 1--Amendments                                          Â                                                                                2

National Health (Pharmaceuticals and Vaccines--Cost Recovery) Regulations 2009          2

 

1  Name

                   This instrument is the National Health (Pharmaceuticals and Vaccines--Cost Recovery) Amendment (Vaccine Advice) Regulations 2019.

2  Commencement

             (1)  Each provision of this instrument specified in column 1 of the table commences, or is taken to have commenced, in accordance with column 2 of the table. Any other statement in column 2 has effect according to its terms.

 

Commencement information
Column 1	Column 2	Column 3
Provisions	Commencement	Date/Details
1.  The whole of this instrument	Immediately after the commencement of the National Health (Pharmaceuticals and Vaccines--Cost Recovery) Amendment Regulations 2019	1 July 2019

Note:          This table relates only to the provisions of this instrument as originally made. It will not be amended to deal with any later amendments of this instrument.

             (2)  Any information in column 3 of the table is not part of this instrument. Information may be inserted in this column, or information in it may be edited, in any published version of this instrument.

3  Authority

                   This instrument is made under the National Health Act 1953.

4  Schedules

                   Each instrument that is specified in a Schedule to this instrument is amended or repealed as set out in the applicable items in the Schedule concerned, and any other item in a Schedule to this instrument has effect according to its terms.

Schedule 1--Amendments

  

National Health (Pharmaceuticals and Vaccines--Cost Recovery) Regulations 2009

1  Regulation 1.3

Insert:

ATAGI advice has the meaning given by subregulation 1A.1(1).

2  Regulation 1A.1

Repeal the regulation, substitute:

1A.1  Fees for providing ATAGI advice

             (1)  On or after 1 July 2020, a person may make an application (the ATAGI application) for the provision of advice (the ATAGI advice) by ATAGI to the person for the person to include in a proposed Part 2 submission to the Committee that the Committee recommend to the Minister that the Minister exercise a power under section 9B of the Act.

             (2)  For the purposes of section 99YBA of the Act, the fee (the usual ATAGI fee) prescribed for providing the ATAGI advice to the person is $300,440 (if the notification for the person's ATAGI application is given during the financial year starting on 1 July 2020).

Note:          This fee is indexed for later financial years (see regulation 4.7).

3  Subregulation 1A.2(3)

Repeal the subregulation, substitute:

Fee payable if a person is partially exempt

             (3)  If a person is partially exempt under subregulation (1), the fee for providing the ATAGI advice to the person is reduced. The reduced fee is $178,550 (if the notification for the person's ATAGI application is given during the financial year starting on 1 July 2020).

Note:          This reduced fee is indexed for later financial years (see regulation 4.7).